Michael E. Sturmer, an insider at Progyny Inc (PGNY), sold 296,210 shares at a price of $25.27 each on December 1, 2025, resulting in a total transaction value of $7.49 million. Following this transaction, Sturmer retains 296,210 shares of the company.
Progyny, headquartered in New York City, specializes in fertility benefits management and employs 675 full-time staff. The company went public on October 25, 2019, and serves approximately 6.7 million employees and their partners through its proprietary Smart Cycle approach, which encompasses all necessary medical services for fertility treatment.
As of November 18, 2025, Progyny has a market capitalization of $2.2 billion, a P/E ratio of 39.21, and an EPS of 0.62. Upcoming earnings are scheduled for May 6, 2026, with an estimated EPS of $0.23 and revenue of $355.3 million.
Insider transactions, such as this sale, are reported to the SEC and offer transparency into executive stock movements. However, they should not solely dictate investment decisions, as various personal or regulatory factors may drive such actions. Investors are encouraged to consider broader patterns of insider activity and other fundamental metrics when evaluating company performance.